The CEDD is committed to the discovery of novel drugs for the treatment and prevention of acquired drug-resistant epilepsy using translationally relevant animal models, discovery and pharmacological validation of novel rodent epilepsy models, and to the training of next-generation epilepsy investigators and healthcare professionals.
Core Services Offered
Antiseizure medicine (ASM) discovery; disease-modification studies, ASM pharmacokinetics and pharmacodynamics, seizure and epilepsy model development; training of undergraduate, graduate and professional students with an interest in preclinical epilepsy research and neurotherapeutics discovery.
National Institute of Neurological Disorders and Stroke, National Institute of Aging, American Epilepsy Society, Washington Research Foundation, and pharmaceutical industry-sponsored research.
Chair, Department of Pharmacy
Related UW Entities
Departments of Pharmacy and Pharmaceutics, UW School of Pharmacy; Departments of Neurology and Neurosurgery, UW School of Medicine; UW Department of Veterinary Medicine; UW Department of Comparative Medicine; UW School of Pharmacy Comparative Health Outcomes, Policy and Economics (CHOICE) Institute; UW School of Pharmacy Plein Center for Geriatric Pharmacy Research, Education and Outreach: UW School of Pharmacy MS in Biomedical Regulatory Affairs (BRAMS Program); UW Center on Human Development and Disability (CHDD), UW Center for Cannabis Research (CCR); UW Center for Exposures, Diseases, Genomics, and Environment (EDGE); UW Addictions, Drug & Alcohol Institute.
University of Utah Anticonvulsant Drug Development Program, Hebrew University of Jerusalem, UCB Pharma